DALLAS, TX, Aug 18, 2025 – MedCAD has contributed to facial reconstruction efforts for individuals injured by the Ukraine Russia war. The company donated patient-specific, 3D-printed titanium facial implants to support surgical procedures led by Dallas oculoplastic surgeon Dr. Jorge Corona. Dr. Corona and a U.S. medical team traveled to Kyiv to perform reconstructive surgeries on four patients who suffered facial injuries due to the war.
“These are not just custom implants – they’re hope made tangible,” said Nancy Hairston, president and CEO of MedCAD. “This mission underscores how American innovation and compassion can directly improve lives, even in the middle of a war zone.”
The patients – at least two of whom are women – required implants to restore facial bone structure. The surgical teams used 3D-printed titanium implants due to its durability and biocompatibility with the human body, critical properties in complex facial reconstruction.
MedCAD worked with Ukrainian doctors, who provided CT scans of the patients’ injuries. Using this data, MedCAD engineers created 3D surgical plans and manufactured titanium implants specific to each patient’s anatomy. The company supplied these implants without charge as part of its ongoing work designing and producing custom implants for surgeons worldwide.
Dr. Corona hand-carried the implants to Kyiv and led the surgical effort. “Witnessing these patients regain not only physical form but also dignity and hope – it’s the most rewarding experience of my career,” he said.
About MedCAD
MedCAD, founded in 2007 and headquartered in Dallas, TX, is a privately held medical technology company specializing in the design and production of patient-matched surgical devices and planning solutions. Using imaging, surgical expertise, and manufacturing methods such as 3D printing and high-precision milling, the company develops personalized implants and surgical plans for cranial defects, oral surgery, cranio-maxillofacial trauma, and reconstructive procedures. MedCAD’s portfolio includes cranial implants, orthognathic guides, maxillofacial plates, anatomical models, and other tools manufactured in-house in collaboration with surgeons. The company earned FDA 510(k) clearance for its AccuShape cranial implant in 2011 and has since delivered more than 8,000 customized solutions. Its technologies aim to reduce surgical complexity and procedure time while supporting improved outcomes in intervention, rehabilitation, and recovery. MedCAD serves surgical specialties including craniofacial reconstruction, neurosurgery, orthognathic surgery, mandibular repair, foot and ankle reconstruction, and trauma care.